This week on Contemporary OB/GYN®: Jan. 31 to Feb. 4
A look at what's coming to Contemporary OB/GYN® this week.
Glenmark Pharmaceuticals gets FDA approval for generic MetroGel
The drug is used to treat bacterial vaginosis and is a generic version of Bausch Health US LLC’s MetroGel-Vaginal.
Balancing the rewards and risks of hormonal acne treatments
Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.
American Heart Month
February is American Heart Month. Each week, explore the facts, statistics, and resources available for women's heart health.
Coming soon
Statin use in midlife women
Risk assessment, lifestyle counseling, adverse effects, and medication management.
Coming soon
February 4: World Cancer Day
Friday marks World Cancer Day, an international awareness campaign led by the Union for International Cancer Control (IUCC). This year's theme is #CloseTheCareGap. Check back for toolkits, infographics, posters and more.
Coming soon
SMFM 2022 Annual Meeting
This week marks the beginning of the Society for Maternal-Fetal Medicine's 2022 Annual Meeting. Join us for the best of this year's virtual presentations, panel discussions, roundtables, and more.
Coming soon
EHR-based models show promise in predicting postpartum depression
December 24th 2024Recent research published highlights the potential of electronic health record data to improve postpartum depression diagnosis, offering a step toward better mental health outcomes for birthing parents.
Read More
Midlife sexual health boosts for nonheterosexual women reported
December 23rd 2024A recent study highlights improved sexual function and reduced distress among nonheterosexual women during menopause compared to their heterosexual counterparts, shedding light on how sexual identity impacts well-being.
Read More
